glp-1 obesity drug news today weight-loss pills are arriving, and adoption is moving fast. Within just three weeks of launch in the U.S., the new oral GLP-1 medication was prescribed to ~170,000 people, reflecting how quickly Obesity Drug Pipeline Expands with

Anthocyanin delphinidin prevents neoplastic transformation of mouse skin JB6 P+ cells: epigenetic Re-activation of Nrf2-ARE pathway

As the terminal enzyme downstream of COX-2, mPGES-1 can catalyze the biosynthesis of PGE 2 with fewer side effects and, ideally, cannot affect the formation of other housekeeping PGs

By incorporating scientifically backed compounds into formulations, the brand ensures that every product delivers real, visible benefits

Acetyl-L-carnitine reduced cortical demyelination to the extent that there was no statistical difference between the demyelination scores of the CTL and CPZ+ALC groups

doi: 10.1016/j.yexcr.2021.112800 179 LiuCSunWZhuTShiSZhangJWangJet al

Radbill B, Murphy B, LeRoith D